Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Junichiro James, Kazama"'
Autor:
Hirotaka Saito, Kenichi Tanaka, Hiroki Ejiri, Hiroshi Kimura, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract A higher heart rate is recognized as an independent risk factor for all-cause mortality and cardiovascular events in the general population. However, the association between elevated heart rate and clinical adverse outcomes in patients with
Externí odkaz:
https://doaj.org/article/55ed71b83ccf4eb99913a8e448d81c9e
Autor:
Hiroshi Kimura, Kenichi Tanaka, Hirotaka Saito, Tsuyoshi Iwasaki, Sakumi Kazama, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract The red blood cell distribution width–albumin ratio (RAR) is a prognostic factor for adverse outcomes in various populations. However, whether RAR is associated with renal outcomes remains unclear. Therefore, we aimed to investigate the im
Externí odkaz:
https://doaj.org/article/92eb0573eb354e3f8a294076dec96460
Autor:
Hiroaki Satoh, Kanako Okazaki, Tetsuya Ohira, Akira Sakai, Mitsuaki Hosoya, Seiji Yasumura, Yukihiko Kawasaki, Koichi Hashimoto, Akira Ohtsuru, Atsushi Takahashi, Kazuyuki Watanabe, Michio Shimabukuro, Junichiro James Kazama, Shigeatsu Hashimoto, Gen Kobashi, Hiromasa Ohira, Hitoshi Ohto, Kenji Kamiya
Publikováno v:
Journal of Epidemiology, Vol 32, Iss 6, Pp 277-282 (2022)
Background: The Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster forced the evacuation of residents and led to many changes in lifestyle for the evacuees. The Comprehensive Health Check was implemented to support the prevention
Externí odkaz:
https://doaj.org/article/99bf4fbb57d442008db7f9c71e82c9b9
Autor:
Kimio Watanabe, Emiko Sato, Eikan Mishima, Shinobu Moriya, Takuma Sakabe, Atsuya Sato, Momoko Fujiwara, Takuya Fujimaru, Yugo Ito, Fumika Taki, Masahiko Nagahama, Kenichi Tanaka, Junichiro James Kazama, Masaaki Nakayama
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 16, p 12752 (2023)
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a new class of medications for managing renal anemia in patients with chronic kidney disease (CKD). In addition to their erythropoietic activity, HIF-PHIs exhibit multifaceted effe
Externí odkaz:
https://doaj.org/article/600b776577b141ffafb03872867bd5a5
Autor:
Kenichi Tanaka, Momoko Fujiwara, Hirotaka Saito, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Hiroshi Kimura, Yoshihiro Tani, Jun Asai, Hodaka Suzuki, Keiji Sato, Junichiro James Kazama
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Responsiveness to erythropoiesis-stimulating agents (ESAs) is thought to be related to prognosis in patients on hemodialysis. A multi-center, prospective cohort study was conducted to investigate the effects of hyporesponsiveness
Externí odkaz:
https://doaj.org/article/8465039857ad4172a570bf080e3311a3
Autor:
Hirotaka Saito, Kenichi Tanaka, Tsuyoshi Iwasaki, Akira Oda, Shuhei Watanabe, Makoto Kanno, Hiroshi Kimura, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract As previous studies have reported finding an association between hyperuricemia and the development of cardiovascular and chronic kidney disease, hyperuricemia is thought to be an independent risk factor for hypertension and diabetic mellitus
Externí odkaz:
https://doaj.org/article/05a79b92278a486b9d5ae6e777f6cab9
Autor:
Hiroe Sato, Chinatsu Takai, Junichiro James Kazama, Ayako Wakamatsu, Eriko Hasegawa, Daisuke Kobayashi, Naoki Kondo, Takeshi Nakatsue, Asami Abe, Satoshi Ito, Hajime Ishikawa, Takeshi Kuroda, Yoshiki Suzuki, Ichiei Narita
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether se
Externí odkaz:
https://doaj.org/article/e643e4fb91bf4a0e9a917114e07306d6
Autor:
Mitsuaki Hosoya, Masanori Nagao, Atsushi Takahashi, Hiromasa Ohira, Tetsuya Ohira, Michio Shimabukuro, Seiji Yasumura, Masaharu Maeda, Mayumi Harigane, Yuriko Suzuki, Hirooki Yabe, Hironori Nakano, Kenji Kamiya, Akira Sakai, Hiroyuki Hirai, Kanako Okazaki, Fumikazu Hayashi, Junichiro James Kazama, Hitoshi Ohto
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/4321231a94ab4b02b0a7b001abb18b15
Autor:
Hiroshi Kimura, Kenichi Tanaka, Hirotaka Saito, Tsuyoshi Iwasaki, Shuhei Watanabe, Sakumi Kazama, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Publikováno v:
Clinical and Experimental Nephrology. 27:272-278
Polypharmacy is common in patients with chronic kidney disease (CKD) and is associated with a decline in kidney function. However, its impact on patients without CKD has not been adequately elucidated. Therefore, we aimed to investigate the associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2c5b926227b0b2bba9efa07297e229
https://doi.org/10.1007/s10157-022-02306-w
https://doi.org/10.1007/s10157-022-02306-w
Autor:
Junichiro James Kazama, Fumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, Kenji Asano, Daisuke Honda, Tadao Akizawa
Publikováno v:
Clinical Pharmacokinetics. 61:1271-1284
Upacicalcet is a new renally excreted and injectable calcimimetic agent. We evaluated the pharmacokinetics, pharmacodynamics, safety, and tolerability of single and multiple intravenous administration of upacicalcet in patients with secondary hyperpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442fb0ce04c41be464648b0db835827b
https://doi.org/10.1007/s40262-022-01139-w
https://doi.org/10.1007/s40262-022-01139-w